title: Preparation and pharmacokinetics of samarium(III)-153-labeled DTPA-bis-biotin. Characterization and theoretical studies of the samarium(III)-152 conjugate.
abstract: The complex(153)Sm(III)DTPA-bis-biotin was prepared with a 99% radiochemical purity and a specific activity of 370 MBq/mg employing a molar ratio of DTPA-bis-biotin/Sm from 2 to 4 at pH 8.0. In vitro studies demonstrated that the complex is stable after dilution in saline and in human serum. Avidity of labeled biotin for avidin was not affected by the labeling procedure. Pharmacokinetic data of (153)Sm(III)DTPA-bis-biotin in normal mice showed that blood clearance is biexponential during the time interval from 0 to 24 h and that 3 h postinjection 92 +/- 4.32% of the dose is eliminated in the urine. To have further evidence which could sustain that (153)Sm(III)DTPA-bis-biotin is stable in solution as a real coordination complex, (152)Sm(III)DTPA-bis-biotin was obtained in macroscopic quantities and its characterization was done by IR, TGA, and conductivity measurements. The results indicated that the complex was chemically pure, where the Sm(3+) ion is neutralized by three carboxylate groups of the DTPA-bis-biotin ligand and coordinated to it. Using the Force Field method followed by ab initio calculations, the DTPA-bis-biotin and the Sm(III)DTPA-bis-biotin molecules were done. Accordingly, the coordination sphere of Sm(III) was totally satisfied with nitrogen and oxygen donors; the best coordination number was 9. The conformation geometry of both compounds is presented.
authors.affiliation: Instituto Nacional de Investigaciones Nucleares, México, Departamento de Materiales Radiactivos, Km. 36.5 Carretera México-Toluca, C.P. 52045. gff@nuclear.inin.mx
authors.forename: G
authors.initials: G
authors.lastname: Ferro-Flores
authors.forename: F D
authors.initials: FD
authors.lastname: Ramírez
authors.forename: J I
authors.initials: JI
authors.lastname: Tendilla
authors.forename: G
authors.initials: G
authors.lastname: Pimentel-González
authors.forename: C A
authors.initials: CA
authors.lastname: Murphy
authors.forename: L
authors.initials: L
authors.lastname: Meléndez-Alafort
authors.forename: J A
authors.initials: JA
authors.lastname: Ascencio
authors.forename: B Y
authors.initials: BY
authors.lastname: Croft
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001710:Biotin / Q000031:analogs & derivatives* / Q000097:blood / Q000138:chemical synthesis / Q000737:chemistry / Q000493:pharmacokinetics; D004355:Drug Stability; D005260:Female; D006358:Hot Temperature; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008958:Models, Molecular; D004369:Pentetic Acid / Q000031:analogs & derivatives* / Q000097:blood / Q000138:chemical synthesis / Q000737:chemistry / Q000493:pharmacokinetics; D011868:Radioisotopes / Q000737:chemistry*; D019275:Radiopharmaceuticals / Q000097:blood / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics*; D012493:Samarium / Q000737:chemistry*; D012996:Solutions; D013055:Spectrophotometry, Infrared; D013818:Thermogravimetry; D014018:Tissue Distribution
chemical_list: C400052:DTPA-bis-biotin; D011868:Radioisotopes; D019275:Radiopharmaceuticals; D012996:Solutions; D012493:Samarium; D001710:Biotin; D004369:Pentetic Acid